A new study
published in Nature
Cell Biology by Mark
Alkema, PhD, professor of neurobiology, establishes an important molecular link
between specific B12-producing bacteria in the gut of the roundworm C.
elegans and the production of
acetylcholine, a neurotransmitter important to memory and cognitive function.
There is growing recognition among
scientists that diet and gut microbiota may play an important role in brain
health. Changes in the composition of the microbiome have been linked to
neurological disorders such as anxiety, depression, migraines and neurodegeneration.
Yet, teasing out the cause and effect of individual bacteria or nutrients on
brain function has been challenging.
“There are more bacteria in your
intestine than you have cells in your body,” said Woo Kyu Kang, PhD, a
postdoctoral fellow in the Alkema lab and first author of the current study.
“The complexity of the brain, the hundreds of bacterial species that comprise
the gut microbiome and the diversity of metabolites make it almost impossible
to discern how bacteria impact brain function.”
To isolate the impact of individual
bacteria on specific brain functions, Dr. Kang fed a diet made up of a single
bacterial species to worms with a mutation that results in an imbalance in
excitatory/inhibitory signaling in the brain and leads to seizure
like-behaviors in the worm. A similar genetic mutation in humans causes
migraines.
Kang fed these mutant C.
elegans diets of a single bacterial
species and watched for changes in seizure frequency. Out of the 40 different
bacterium diets he tested, 18 reduced the number of seizures. Further
experiments showed that the common attribute between a number of these bacteria
was their ability to produce vitamin B12.
According to Dr. Alkema and Kang, B12
reduces the levels of choline in the body. Choline, a compound found in various
foods and essential to metabolizing fat in the liver, can be used in the
B12-dependent methionine/S-adenosyl methionine (Met/SAM) cycle, a metabolic
pathway that produces methionine (an amino acid acquired by humans through diet
that is essential to metabolism) in the intestine. However, choline is also
used to make the neurotransmitter acetylcholine in the nervous system. Too much
acetylcholine leads to the excitatory imbalance that causes the seizure-like
behavior in the mutant worms.
When more B12 is present, more choline
is used in the Met/SAM cycle, leaving less choline to produce acetylcholine.
Reducing the amount of acetylcholine restores the excitatory/inhibitory balance
in the nervous system and reduces seizure activity in C.
elegans.
The researchers pointed out that the
impact of “crosstalk” between the microbiome, vitamin B12, brain function and
behavior only become apparent under conditions where the organism is stressed
either genetically or environmentally. A deficiency of B12 in humans has been
associated with neurological disorders that are characterized by
excitatory/inhibitory imbalance such as schizophrenia, depression and migraine
headaches.
“It will be interesting to determine
whether the molecular mechanisms discovered in the worm can also explain the
impact of B12 on excitatory signaling in several human neurological disorders,”
said Alkema.
By using other worm models for other
human diseases and testing other metabolites and bacteria, Alkema and
colleagues hope to reveal other connections between the gut microbiome and
brain function that can also be used to improve human health.
No comments:
Post a Comment